Ventas (NYSE: VTR) and Global Medical REIT (NASDAQ:GMRE) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations and earnings.

Analyst Recommendations

This is a breakdown of current ratings for Ventas and Global Medical REIT, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ventas 4 5 1 0 1.70
Global Medical REIT 0 2 4 0 2.67

Ventas presently has a consensus target price of $61.57, indicating a potential downside of 9.55%. Global Medical REIT has a consensus target price of $10.83, indicating a potential upside of 24.24%. Given Global Medical REIT’s stronger consensus rating and higher probable upside, analysts clearly believe Global Medical REIT is more favorable than Ventas.

Insider & Institutional Ownership

89.2% of Ventas shares are held by institutional investors. 1.3% of Ventas shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Ventas and Global Medical REIT’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Ventas $3.52 billion 6.89 $1.88 billion $1.97 34.55
Global Medical REIT N/A N/A N/A N/A N/A

Ventas has higher revenue and earnings than Global Medical REIT.

Dividends

Ventas pays an annual dividend of $3.10 per share and has a dividend yield of 4.6%. Global Medical REIT does not pay a dividend. Ventas pays out 157.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas has increased its dividend for 6 consecutive years.

Profitability

This table compares Ventas and Global Medical REIT’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ventas 20.08% 6.31% 2.81%
Global Medical REIT -8.39% -1.53% -0.72%

Summary

Ventas beats Global Medical REIT on 8 of the 12 factors compared between the two stocks.

Ventas Company Profile

Ventas, Inc. is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses. In its senior living operations segment, it invests in seniors housing communities throughout the United States and Canada and engages independent operators to manage those communities. In its office operations segment, the Company primarily acquires, owns, develops, leases and manages medical office buildings (MOBs) and life science and innovation centers throughout the United States.

Global Medical REIT Company Profile

Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.

Receive News & Ratings for Ventas Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas Inc. and related companies with MarketBeat.com's FREE daily email newsletter.